関連する実験動画
Updated: Sep 9, 2025

08:25
Identification of Circular RNAs using RNA Sequencing
Published on: November 14, 2019
12.4K
循環型RNAとがん
Mohammad Mahdi Heidari1,2,3, Mohammad Saeid Moeinfar2,3, Mahdi Rafiyan2,3
1Department of Pediatric, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Advances in experimental medicine and biology
|August 31, 2025
まとめ
円形RNA (circRNAs) は,細胞機能において重要な役割を果たす新しいRNA分子である. 腫瘍に異常な存在は癌の成長を促し 臨床バイオマーカーや治療標的として 潜在的可能性を秘めています
科学分野:
- 分子生物学
- 遺伝学
- 腫瘍学
背景:
- 円形RNA (circRNAs) は,前mRNAのバックスプライシングによって形成される内生RNA分子である.
- 独特の円形構造を備えています
- 新興する役割には,マイクロRNAのスポンジ化,タンパク質の構造,遺伝子発現の調節が含まれます.
研究 の 目的:
- 癌におけるcircRNA研究における進歩を検証する.
- 分子メカニズムに 焦点を当てるように
- その臨床的意義を探るためだ
主な方法:
- 癌におけるcircRNAに関する現在の科学文献のレビュー.
- 腫瘍形成におけるcircRNA機能の基礎となる分子機構の分析.
- 潜在的臨床バイオマーカーおよび治療標的としてのcircRNAの評価
主要な成果:
- 異常なcircRNA発現は腫瘍の進行と関連しています.
- CircRNAは制御不能な細胞増殖,侵入,細胞死回避に寄与する.
- 調節不良のサークルRNAは,様々な癌において重要な役割を果たします.
結論:
- CircRNAsは主要な癌の特徴に関与しています.
- 独特の特性により 診断マーカーとしての可能性が示唆されています
- CircRNAは新しいがん治療の有望なターゲットです
関連する概念動画
lncRNA - Long Non-coding RNAs
8.9K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.9K
Rous Sarcoma Virus (RSV) and Cancer
5.4K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
5.4K
MicroRNAs
3.1K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.1K
Experimental RNAi
6.2K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.2K
Mechanisms of Retrovirus-induced Cancers
5.3K
Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
5.3K
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K

